BeatO, a diabetes care startup, raises series B funding of $33 million from Lightrock

Diabetes care startup raises $33 million in series B funding. BeatO aims to become India’s largest diabetes care company. The funds will be used to expand diabetes care programmes and strengthen the leadership team, products and technology.

BeatO, a diabetes care startup, raises series B funding of $33 million from Lightrock

Digital solution for Diabetes care platform BeatO on November 16 announced that it had raised $33 million (around Rs 269 Crores) in a Series B funding led by Lightrock India with participation from Flipkart, HealthQuad and existing investors.

The funds will be used to expand diabetes care programmes pan-India, strengthening the leadership team and invest in products and technology. 

BeatO was founded by Gautam Chopra, Yash Sehgal and Kunal Kinalekar in 2015. The startup provides affordable, comprehensive and patient-centric digital solutions to people with diabetes, who have limited access to good quality and continuous care.

Gautam Chopra, Co-Founder and CEO, said that “With our digital first solution, BeatO is well positioned to lay new standards of how care will be delivered in the future to millions of Indians. We are pleased to have a fantastic set of partners joining us on the journey who deeply resonate with our vision and bring solid capabilities to help us achieve our goal.” BeatO aims to serve over 10 million patients by 2025, to become India’s largest diabetes care company.

(Edited by Rajeev Pillai)

 

Tags : #fundingalert #beato #diabetescare #diabetes #health #diabetic #diabetestype #diabetesawareness #funding #startup #flipkart #healthquad #lightrock #medicircle #smitakumar

About the Author


Rajeev Pillai

Rajeev Pillai has accumulated extensive experience in the Electronics and Telecom Service Industry with global companies in the Middle East. Being a continuous learner with a lifelong passion for writing, Rajeev writes on topics such as Healthcare, Finance, Travel and Technology.

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Karan Johar and Guneet Monga Kapoor’s 'Gyaarah Gyaarah' trailer breaks time barriers on ZEE5July 26, 2024
If some countries in Asia Pacific can be on track to end AIDS then why cannot all?July 26, 2024
Investing in India’s Path to a Healthier and Brighter FutureJuly 26, 2024
Your Medication Could Be Useless This Summer: How Heat Waves Affect Drug SafetyJuly 26, 2024
Innovative Approach to Adolescent Weight Loss: Combining Meal-Replacement Therapy with Financial IncentivesJuly 26, 2024
Promoting School Cardiopulmonary Resuscitation (CPR) Program in India: A Step Towards Saving LivesJuly 26, 2024
Education Budget 2024: A Step Towards Better Learning : Gargi Limaye July 25, 2024
AI assistant shows great promise in cataract care pathwayJuly 25, 2024
Publishing Powerhouse Devangini : A Force of Resilience and Empowerment in LiteratureJuly 25, 2024
Alarm rings in Asia Pacific for not making U-equals-U and HIV prevention accessible to allJuly 25, 2024
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular DiseasesJuly 24, 2024
Nurturing Souls revolutionises 1000 Child-Parent Relationships for Better Career Choices & improved Mental HealthJuly 24, 2024
How to Improve Sleep Quality in Adolescents: Insights from a New StudyJuly 24, 2024
Tragic Nipah Virus Death of 14-Year-Old in Kerala: What You Need to KnowJuly 24, 2024
India Inaugurates First Overseas Jan Aushadi Kendra in MauritiusJuly 24, 2024
Budget Reaction Quote - Ms. Deepshikha Sharma, CEO, Sharp Sight Eye HospitalsJuly 23, 2024
Quote to be attributed to Mr. Jatinder Paul Singh, CEO & Co - Founder of Viacation Tourism:July 23, 2024
Budget Reaction by Anjan Bose, Founding Secretary General, NATHEALTH July 23, 2024
Mr. Niranjan Kirloskar, Managing Director, Fleetguard Filters Private Limited- BUDGET REACTIONJuly 23, 2024